1. Swartling FJ*, Savov V, Persson AI, Chen J, Hackett, CS, Grimmer MR, Northcott PA, Lau J, Chesler L, Perry A, Phillips JJ, Taylor MD and Weiss WA. Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC. Cancer Cell 21:601-13. (2012). ⃰Corresponding author.
2. Põlajeva J, Swartling FJ, Jiang Y, Singh U, Uhrbom L, Westermark B and Roswall P. miRNA-21 is developmentally regulated in mouse brain and maintains SOX2 expression in glioma. BMC Cancer 12:378-85 (2012).
3. Swartling FJ, Grimmer MR, Hackett CS, Northcott PA, Fan QW, Goldenberg DD, Lau J, Masic S, Collins R, Nguyen K, Yakovenko S, Zhe XN, Flynn Gilmer HC, Nagaoka M, Phillips JJ, Jenkins RB, Tihan T, Vandenberg SR, James CD, Tanaka K, Taylor MD, Weiss WA and Chesler L. Pleiotropic role for MYCN in medulloblastoma. Genes and Development 24:1059-72 (2010).
4. Persson AI, Petrisch C⃰, Swartling FJ⃰, Melissa I, Goldenberg DD, Vandenberg SR, Nguyen KN, Yakovenko S, Ayers-Ringler J, Thorne CA, Lee E, Nishiyama A, Stallcup WB, Berger MS, Bergers G, McKnight TR and Weiss WA. Non-stem cell origin for oligodendroglioma. Cancer Cell 18: 669- 682. (2010). ⃰Equal contribution.
5. Swartling FJ, Ferletta M., Kastemar M., Weiss WA., Westermark B. Cyclic GMPdependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene 28: 3121-31. (2009).
6. Johansson (Swartling) FK, Goransson H, Westermark B. Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene 24:3896-905 (2005).
7. Uhrbom L, Kastemar M, Johansson (Swartling) FK, Westermark, B, Holland EC. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis. Cancer Res. 65:2065-9 (2005).
8. Johansson (Swartling) FK, Brodd J, Eklof C, Ferletta M, Hesselager G, Tiger CF, Uhrbom L, Westermark, B. Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging. Proc Natl Acad Sci USA 101:11334-7 (2004).
9. Hede SM, Savov V, Weishaupt H, Sangfelt O and Swartling FJ. Oncoprotein stability in brain tumors. Invited Review, Oncogene, May (2013).
10. Swartling FJ, Bolin S, Phillips JJ, and Persson AI. Signals that regulate the oncogenic fate of neural stem cells and progenitors. Review. Exp. Neurol. Jan (2013)